Cyclin-dependent kinase 8 is an independent prognosticator in uterine leiomyosarcoma
- 26 April 2022
- journal article
- research article
- Published by Elsevier in Pathology - Research and Practice
- Vol. 235, 153920
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- MED12 mutations in leiomyosarcoma and extrauterine leiomyomaLaboratory Investigation, 2013
- Uterine Leiomyosarcoma Management, Outcome, and Associated Molecular Biomarkers: A Single Institution’s ExperienceAnnals of Surgical Oncology, 2013
- Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activitiesProceedings of the National Academy of Sciences, 2012
- MED12 Alterations in Both Human Benign and Malignant Uterine Soft Tissue TumorsPLOS ONE, 2012
- Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancerNature Genetics, 2012
- MED12, theMediator Complex Subunit 12Gene, Is Mutated at High Frequency in Uterine LeiomyomasScience, 2011
- Revving the Throttle on an Oncogene: CDK8 Takes the Driver SeatCancer Research, 2009
- Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patientsHistopathology, 2009
- CDK8 is a colorectal cancer oncogene that regulates β-catenin activityNature, 2008
- Drosophila Cdk8, a kinase partner of cyclin C that interacts with the large subunit of RNA polymerase II.Molecular Biology of the Cell, 1996